a16z|Nov 03, 2026 18:53
Half of 500 Americans surveyed have heard of peptides beyond GLP-1s
Why the 62 self-reported users take them:
- 50% for performance
- 45% for recovery
- 36% for appearance
- 27% for longevity
- 23% for sleep
"Peptide medicines with robust consumer pull can create an unusually efficient path to patients, and we suspect this dynamic could extend to other disease areas, including sleep, bone health, and cardiovascular health."
Full longevity survey breakdown from a16z's Daisy Wolf and Eva Steinman: https://www.a16z.news/p/the-state-of-longevity
Share To
Timeline
HotFlash
APP
X
Telegram
CopyLink